185 related articles for article (PubMed ID: 28854163)
1. Decreasing Eukaryotic Initiation Factor 3C (EIF3C) Suppresses Proliferation and Stimulates Apoptosis in Breast Cancer Cell Lines Through Mammalian Target of Rapamycin (mTOR) Pathway.
Zhao W; Li X; Wang J; Wang C; Jia Y; Yuan S; Huang Y; Shi Y; Tong Z
Med Sci Monit; 2017 Aug; 23():4182-4191. PubMed ID: 28854163
[TBL] [Abstract][Full Text] [Related]
2. Eukaryotic initiation factor 3C silencing inhibits cell proliferation and promotes apoptosis in human glioma.
Hao J; Wang Z; Wang Y; Liang Z; Zhang X; Zhao Z; Jiao B
Oncol Rep; 2015 Jun; 33(6):2954-62. PubMed ID: 25823503
[TBL] [Abstract][Full Text] [Related]
3. EIF3C Promotes Lung Cancer Tumorigenesis by Regulating the APP/HSPA1A/LMNB1 Axis.
Ding X; Hou L; Zhang H; Chen Z; Liu Z; Gong J; Tang Z; Hu R
Dis Markers; 2022; 2022():9464094. PubMed ID: 36157221
[TBL] [Abstract][Full Text] [Related]
4. Effect of siRNA-mediated knockdown of eIF3c gene on survival of colon cancer cells.
Song N; Wang Y; Gu XD; Chen ZY; Shi LB
J Zhejiang Univ Sci B; 2013 Jun; 14(6):451-9. PubMed ID: 23733421
[TBL] [Abstract][Full Text] [Related]
5. The Prognostic Significance of
Hu J; Luo H; Xu Y; Luo G; Xu S; Zhu J; Song D; Sun Z; Kuang Y
Cancer Invest; 2019; 37(4-5):199-208. PubMed ID: 31181967
[TBL] [Abstract][Full Text] [Related]
6. Upregulated expression of eIF3C is associated with malignant behavior in renal cell carcinoma.
Fan M; Wang K; Wei X; Yao H; Chen Z; He X
Int J Oncol; 2019 Dec; 55(6):1385-1395. PubMed ID: 31638200
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X
Gene; 2019 May; 698():50-60. PubMed ID: 30822475
[TBL] [Abstract][Full Text] [Related]
8. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells.
Li JP; Yang YX; Liu QL; Pan ST; He ZX; Zhang X; Yang T; Chen XW; Wang D; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1627-52. PubMed ID: 25834401
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of EIF3C promotes human U-2OS cells apoptosis through increased CASP3/7 and Chk1/2 by upregulating SAPK/JNK.
Gao W; Hu Y; Zhang Z; Du G; Yin L; Yin Z
Onco Targets Ther; 2019; 12():1225-1235. PubMed ID: 30863090
[TBL] [Abstract][Full Text] [Related]
10. Osteopontin knockdown inhibits αv,β3 integrin-induced cell migration and invasion and promotes apoptosis of breast cancer cells by inducing autophagy and inactivating the PI3K/Akt/mTOR pathway.
Zhang H; Guo M; Chen JH; Wang Z; Du XF; Liu PX; Li WH
Cell Physiol Biochem; 2014; 33(4):991-1002. PubMed ID: 24714122
[TBL] [Abstract][Full Text] [Related]
11. Eukaryotic initiation factor 3, subunit C silencing inhibits cell proliferation and promotes apoptosis in human ovarian cancer cells.
Wen F; Wu ZY; Nie L; Zhang QZ; Qin YK; Zhou ZL; Wu JJ; Zhao X; Tan J; Sawmiller D; Zi D
Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31316002
[TBL] [Abstract][Full Text] [Related]
12. Long Non-Coding RNA (lncRNA) Urothelial Carcinoma-Associated 1 (UCA1) Enhances Tamoxifen Resistance in Breast Cancer Cells via Inhibiting mTOR Signaling Pathway.
Wu C; Luo J
Med Sci Monit; 2016 Oct; 22():3860-3867. PubMed ID: 27765938
[TBL] [Abstract][Full Text] [Related]
13. EG-VEGF silencing inhibits cell proliferation and promotes cell apoptosis in pancreatic carcinoma via PI3K/AKT/mTOR signaling pathway.
Yan X; Hui Y; Hua Y; Huang L; Wang L; Peng F; Tang C; Liu D; Song J; Wang F
Biomed Pharmacother; 2019 Jan; 109():762-769. PubMed ID: 30551529
[TBL] [Abstract][Full Text] [Related]
14. Ampelopsin suppresses breast carcinogenesis by inhibiting the mTOR signalling pathway.
Chang H; Peng X; Bai Q; Zhou Y; Yu X; Zhang Q; Zhu J; Mi M
Carcinogenesis; 2014 Aug; 35(8):1847-54. PubMed ID: 24861637
[TBL] [Abstract][Full Text] [Related]
15. Effects of endoplasmic reticulum stress on the autophagy, apoptosis, and chemotherapy resistance of human breast cancer cells by regulating the PI3K/AKT/mTOR signaling pathway.
Zhong JT; Yu J; Wang HJ; Shi Y; Zhao TS; He BX; Qiao B; Feng ZW
Tumour Biol; 2017 May; 39(5):1010428317697562. PubMed ID: 28459209
[TBL] [Abstract][Full Text] [Related]
16. Schwannomin inhibits tumorigenesis through direct interaction with the eukaryotic initiation factor subunit c (eIF3c).
Scoles DR; Yong WH; Qin Y; Wawrowsky K; Pulst SM
Hum Mol Genet; 2006 Apr; 15(7):1059-70. PubMed ID: 16497727
[TBL] [Abstract][Full Text] [Related]
17. Derlin1 functions as an oncogene in cervical cancer via AKT/mTOR signaling pathway.
Li L; Liu M; Zhang Z; Zhang W; Liu N; Sheng X; Wei P
Biol Res; 2019 Feb; 52(1):8. PubMed ID: 30808417
[TBL] [Abstract][Full Text] [Related]
18. Simvastatin-induced breast cancer cell death and deactivation of PI3K/Akt and MAPK/ERK signalling are reversed by metabolic products of the mevalonate pathway.
Wang T; Seah S; Loh X; Chan CW; Hartman M; Goh BC; Lee SC
Oncotarget; 2016 Jan; 7(3):2532-44. PubMed ID: 26565813
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of FHL2 promotes tumorigenesis in cervical cancer and is correlated with poor prognosis.
Jin X; Jiao X; Jiao J; Zhang T; Cui B
Gene; 2018 Aug; 669():99-106. PubMed ID: 29800735
[TBL] [Abstract][Full Text] [Related]
20. MiR-20a suppresses proliferation and facilitates apoptosis of breast cancer cells via the MTOR signaling pathway.
Shi KY; Fan LY; Xu D; Ren LP; Wang LP; Chen LY; Wang LJ
Eur Rev Med Pharmacol Sci; 2020 Nov; 24(22):11650-11657. PubMed ID: 33275232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
